🎉 Congrats to Conemaugh Memorial Medical Center on earning Chest Pain Center and Heart Failure Accreditation.
Thanks for partnering with #ACCAccreditation to advance CV care. Learn more at #FindYourHeartAHome ➡️ bit.ly/42L1CmV
⚠️ New #JACCINT analysis from #COAPT and MITRA-FR identifies 3 SMR phenotypes, showing that #MTEER benefit varies by baseline risk, comorbidities, and extent of cardiac damage. A strong case for more personalized treatment strategies. ow.ly/zAje50Z2eES#vhdMR
đź«€ A striking superior sectional view of the cardiac apex, published in #JACC in collaboration with the #AmaraYadProject, offers a remarkable look at cardiac anatomy and the structure behind function. Worth a closer look: ow.ly/YCxV50Z2ezI#anatomy@shivkumarmd
Recovery after PE isn’t always simple. This piece highlights the human side of healing—what patients carry forward physically, emotionally, and beyond the hospital stay. ❤️ Read more in #JACC: ow.ly/IU0850YKrrk#PulmonaryEmbolism@UjuetaFrancisco
The joint EAPC/ESC and ACC Clinical Consensus Statement offers an in-depth update on abnormal CV findings in Masters athletes—an important resource for clinicians navigating sports participation, evaluation, and risk in aging athletes.
👉 bit.ly/4vnexZx#SportsCardio
Catheter-based therapies are taking on a growing role in #PulmonaryEmbolism care. This article explores where they fit within the new guideline framework—and what that means for patient selection, timing, and treatment strategy. #JACCow.ly/GpMJ50YKrfX#CathLab@GBarnesMD
ICYMI: Drs. John Spertus (@jspertus) and Harmony Reynolds unpack key insights from the #ACC26 HARP-Plus MINOCA study in a Quick Takes video on #ACCAnywhere. A useful watch for a fast take on the findings and their clinical relevance. 📹 bit.ly/4caoHW1#CardioX
Despite fewer bleeding complications in high-risk #PulmonaryEmbolism, mortality has not improved—highlighting persistent challenges in caring for the sickest PE patients. Read more in #JACC: ow.ly/9ZRh50YKr9h@RosovskyRachel
Built for the whole CV care team, the 12th Annual Cardiovascular Symposium returns on October 24, 2026 at the Overland Park Convention Center. Save the date and plan to join colleagues from across Kansas. #KSACC#Cardiology
🧠💓 This month’s thoughtful #JACCBTS editorial page looks at several recent high-impact papers exploring how the nervous system and the heart are deeply intertwined. Read more from EiC Dr. @MatthiasNahrend and Dr. Kevin King: ow.ly/cuL250YKr0e#cvMI
🆕 #JACC Spotlight Issue puts acute #PulmonaryEmbolism guidance into a patient-centered journey—from risk factors and diagnosis to treatment, long-term management, and gaps that still need clarification. Worth a look across the full care continuum: bit.ly/4vlUivh
CV care in Asian populations calls for tailored approaches. New recommendations in this #JACCAsia study highlight key differences in risk and management—an important step toward more precise, population-specific care. ow.ly/kuoh50YKqUE#cvPrev#GlobalHealth
A day for the whole CV care team is coming this fall.
Save the date for the 12th Annual Cardiovascular Symposium on October 24, 2026 at the Overland Park Convention Center. More details to come. #KSACC#Cardiology
🍟 New MESA data at #ACC26 link higher ultraprocessed food intake to greater #ASCVD risk—with an even stronger association among Black Americans. Important findings at the intersection of diet, equity, and CV prevention. More: bit.ly/4bBxAX2#CardioX#JACCAdvances
Looking to get more involved in advocacy? ACC members can take action through Action Alerts, the Advocate Checklist, legislator practice visits and more. You can also text ACC to 50457 for Action Alerts.
Learn more: ow.ly/JR8r50YP7uO#KSACC#ACCAdvocacy
🫀 In childhood cancer survivors, daunorubicin (~0.6) and mitoxantrone (~10.5) showed CTRCD doses risk-equivalent to doxorubicin—helping refine cardiac surveillance. Evidence remains insufficient for epirubicin and idarubicin. ow.ly/kPPn50YKqKN#JACCCardioOnc#cvPed
KSACC is offering travel scholarship support for 2 FITs to attend the ACC Legislative Conference in Washington, DC, Oct. 4 to 6, 2026. Each recipient will receive a $2,000 scholarship. Apply by Aug. 1 at ksacc@qabs.com.
#KSACC#ACCAdvocacy#Cardiology
🎧 In #EaglesEyeView, Dr. @keaglemd highlights key #ACC26 trials, including CHAMPION-AF, VESALIUS-CV, Ez-PAVE, PRO-TAVI more. A strong listen for a quick roundup of practice-shaping science and standout meeting takeaways. 👉 bit.ly/4vzBdpE